Nanoform Finland (OHEL:NANOFH) Equity-to-Asset : 0.86 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Nanoform Finland Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Nanoform Finland's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €66.95 Mil. Nanoform Finland's Total Assets for the quarter that ended in Dec. 2023 was €78.14 Mil. Therefore, Nanoform Finland's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.86.

The historical rank and industry rank for Nanoform Finland's Equity-to-Asset or its related term are showing as below:

OHEL:NANOFH' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.31 Med: 0.73 Max: 0.87
Current: 0.86

During the past 8 years, the highest Equity to Asset Ratio of Nanoform Finland was 0.87. The lowest was -0.31. And the median was 0.73.

OHEL:NANOFH's Equity-to-Asset is ranked better than
77.61% of 1559 companies
in the Biotechnology industry
Industry Median: 0.67 vs OHEL:NANOFH: 0.86

Nanoform Finland Equity-to-Asset Historical Data

The historical data trend for Nanoform Finland's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanoform Finland Equity-to-Asset Chart

Nanoform Finland Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

Get a 7-Day Free Trial

0.61

0.85

0.87

0.86

Nanoform Finland Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial															0.87	0.86	0.86	0.87	0.86

Competitive Comparison of Nanoform Finland's Equity-to-Asset

For the Biotechnology subindustry, Nanoform Finland's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanoform Finland's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanoform Finland's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Nanoform Finland's Equity-to-Asset falls into.

Nanoform Finland Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Nanoform Finland's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	66.947	/	78.135
	=	0.86

Nanoform Finland's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	66.947	/	78.135
	=	0.86

Nanoform Finland (OHEL:NANOFH) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Nanoform Finland Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Nanoform Finland's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanoform Finland (OHEL:NANOFH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanoform Finland PLC (OHEL:NANOFH) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

NANOFS:Sweden 4YL:Germany

Address

Cultivator II, Viikinkaari 4, Helsinki, FIN, 00790

Website

https://www.nanoform.com

Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and by improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications.

Nanoform Finland (OHEL:NANOFH) Headlines

No Headlines